Volume 27, Number 11—November 2021
Research
Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar
Figure 1

Figure 1. Genomic profiling of Mycobacterium tuberculosis strains, Myanmar, comparing discriminatory power offered by GeneXpert (Cepheid, https://www.cepheid.com) and additional genotypic testing, such as line-probe assay or whole-genome sequencing. RIF resistance and sensitivity were determined by using the Xpert MTB/RIF assay (Cepheid). INH, isoniazid; MDR, multidrug resistant; RIF, rifampin; RR, rifampin resistant; RS rifampin sensitive; XDR, extensively drug resistant. *Resistance profile confirmed by phenotypic testing.
1These authors contributed equally to this article.